ACTRN12616000321448已完成2 期
Outpatient Terlipressin Infusion for the Treatment of Refractory Ascites.
Paul Gow0 个研究点目标入组 5 人开始时间: 2016年3月10日最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 5
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
- 分配方式
- Non-randomised trial
- 主要目的
- Treatment
入排标准
- 年龄范围
- 18 Years 至 o limit（—）
- 性别
- All
入选标准
- •Inclusion criteria were refractory ascites secondary to cirrhosis requiring at least fortnightly large volume paracentesis and age greater than 18. It was also necessary for patient’s to have a stable therapeutic paracentesis frequency for at least 3 months.
排除标准
- •Exclusion criteria were: acute coronary syndrome within the past 6 months of enrolment or ongoing angina, prior intolerance to terlipressin, spontaneous bacterial peritonitis in the last 1 month, hepatic vein thrombosis or acute portal vein thrombosis, change in the dose of diuretics within the 30 days preceding the study or anemia with a hemoglobin below 70 mg/dl. The study was approved by the local Human Research Ethics Committee (HREC) and all patients provided written informed consent to participate.
研究者
相似试验
尚未招募
3 期
Outpatient terlipressin infusion for the prevention of liver events in cirrhosiscirrhosisACTRN12624000903583Austin Health100
已完成
不适用
To compare low cost treatment regimen with standard treatment in patients with hepatorenal syndromeCTRI/2011/07/001860il80
已完成
不适用
A controlled trial of terlipressin plus banding ligation versus terlipressin alone in the management of acute esophageal variceal bleedingAcute oesophageal variceal bleeding but stopped bleeding during emergency endoscopyNutritional, Metabolic, EndocrineOesophageal varicesISRCTN28353453Republic of China National Science Council (Taiwan)120
已完成
不适用
Terlipressin infusion for prevention of vasoplegic syndrome in patients treated with ARBs undergoing CABGCirculatory Systemvasoplegic syndrome, coronary artery bypass graft surgeryPACTR201804003249274Ain Shams University Hospitals100
已完成
3 期
The impact of continuous terlipressin infusion on complications of end-stage liver diseaseSarcopaeniaInflammationMalnutritionAscitesInfectionImmune functionOral and Gastrointestinal - Other diseases of the mouth, teeth, oesophagus, digestive system including liver and colonMusculoskeletal - Other muscular and skeletal disordersDiet and Nutrition - Other diet and nutrition disordersInflammatory and Immune System - Other inflammatory or immune system disordersCirrhosisHepatic encephalopathyACTRN12619000891123Austin Health30